Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
China · Delayed Price · Currency is CNY 16.86
+0.10 (0.60%)
Jul 31, 2026, 3:00 PM CST
SHA:601607 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 56,544 | 59,215 | 69,396 | 56,107 | 60,072 | 49,277 | |
Market Cap Growth | -12.73% | -14.67% | 23.68% | -6.60% | 21.91% | 3.75% |
Enterprise Value | 88,428 | 87,415 | 95,555 | 80,065 | 81,075 | 76,701 |
Last Close Price | 16.86 | 17.38 | 20.12 | 15.64 | 16.18 | 17.60 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.79 | 10.34 | 15.24 | 14.89 | 10.69 | 9.68 |
Forward PE | 11.97 | 22.12 | 22.41 | 8.08 | 14.04 | 10.35 |
PS Ratio | 0.20 | 0.21 | 0.25 | 0.22 | 0.26 | 0.23 |
PB Ratio | 0.62 | 0.66 | 0.83 | 0.70 | 0.77 | 0.83 |
P/TBV Ratio | 1.01 | 1.09 | 1.26 | 1.10 | 1.21 | 1.54 |
P/FCF Ratio | 11.16 | 15.47 | 20.25 | 24.82 | 29.18 | 52.28 |
P/OCF Ratio | 7.69 | 9.62 | 11.91 | 10.73 | 12.67 | 9.74 |
PEG Ratio | - | 1.61 | 1.51 | 0.67 | 1.17 | 0.76 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.31 | 0.31 | 0.35 | 0.31 | 0.35 | 0.36 |
EV/EBITDA Ratio | 7.61 | 8.36 | 8.68 | 7.94 | 8.37 | 8.55 |
EV/EBIT Ratio | 10.04 | 10.33 | 10.26 | 9.33 | 9.93 | 10.27 |
EV/FCF Ratio | 17.46 | 22.83 | 27.89 | 35.41 | 39.39 | 81.38 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.64 | 0.64 | 0.65 | 0.65 | 0.57 | 0.69 |
Debt / EBITDA Ratio | 5.06 | 5.11 | 4.66 | 4.82 | 4.29 | 4.24 |
Debt / FCF Ratio | 11.61 | 14.95 | 15.95 | 22.96 | 21.67 | 43.25 |
Net Debt / Equity Ratio | 0.19 | 0.16 | 0.12 | 0.14 | 0.10 | 0.31 |
Net Debt / EBITDA Ratio | 1.63 | 1.35 | 0.93 | 1.12 | 0.78 | 2.05 |
Net Debt / FCF Ratio | 3.50 | 3.69 | 3.00 | 4.97 | 3.69 | 19.49 |
Asset Turnover | 1.25 | 1.25 | 1.27 | 1.27 | 1.28 | 1.38 |
Inventory Turnover | 6.46 | 6.01 | 6.48 | 6.45 | 6.55 | 7.32 |
Quick Ratio | 1.01 | 0.97 | 1.02 | 0.98 | 0.99 | 0.93 |
Current Ratio | 1.34 | 1.34 | 1.36 | 1.33 | 1.35 | 1.27 |
Return on Equity (ROE) | 8.13% | 8.04% | 7.16% | 6.53% | 10.20% | 11.03% |
Return on Assets (ROA) | 2.39% | 2.33% | 2.69% | 2.61% | 2.82% | 2.99% |
Return on Invested Capital (ROIC) | 5.89% | 6.07% | 7.35% | 7.09% | 7.95% | 7.85% |
Return on Capital Employed (ROCE) | 8.90% | 8.60% | 9.80% | 9.60% | 9.30% | 10.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 10.27% | 9.67% | 6.56% | 6.72% | 9.35% | 10.34% |
FCF Yield | 8.96% | 6.46% | 4.94% | 4.03% | 3.43% | 1.91% |
Dividend Yield | 2.79% | 2.71% | 1.84% | 2.62% | 3.77% | 2.39% |
Payout Ratio | 52.81% | 48.91% | 79.16% | 105.66% | 55.08% | 52.54% |
Buyback Yield / Dilution | 0.13% | -0.11% | -0.07% | -6.28% | -22.54% | - |
Total Shareholder Return | 2.93% | 2.59% | 1.76% | -3.65% | -18.77% | 2.39% |